David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$436M |
| 2 |
AbbVie
ABBV
|
+$407M |
| 3 |
Johnson & Johnson
JNJ
|
+$295M |
| 4 |
Gilead Sciences
GILD
|
+$267M |
| 5 |
Starbucks
SBUX
|
+$230M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$407M |
| 2 |
Booking.com
BKNG
|
+$400M |
| 3 |
Citigroup
C
|
+$314M |
| 4 |
SHPG
Shire pic
SHPG
|
+$276M |
| 5 |
PayPal
PYPL
|
+$257M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 23.09% |
| 2 | Technology | 17.04% |
| 3 | Healthcare | 13.44% |
| 4 | Consumer Discretionary | 13.38% |
| 5 | Financials | 7.19% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
VMW
2226
PUT
DELISTED
VMware, Inc
VMW
| $1.72M | ﹤0.01% |
9,500
| – | – |
|
|
XONE
2227
DELISTED
The ExOne Company
XONE
| $1.71M | ﹤0.01% |
201,851
+92,544
| +85% | +$854K |
|
|
SGMO
2228
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
| $1.71M | ﹤0.01% |
179,575
-89,113
| -33% | -$910K |
|
2229
Wabash National
WNC
$528M
| $1.71M | ﹤0.01% |
126,354
+107,923
| +586% | +$1.53M |
|
2230
AptarGroup
ATR
$8.49B
| $1.71M | ﹤0.01% |
16,051
+5,266
| +49% | +$526K |
|
2231
CALL
Paychex
PAYX
$45.2B
| $1.71M | ﹤0.01% |
21,300
-48,400
| -69% | -$3.57M |
|
2232
Compañía de Cervecerías Unidas
CCU
$2.28B
| $1.7M | ﹤0.01% |
57,815
+23,056
| +66% | +$643K |
|
2233
Agilysys
AGYS
$3.4B
| $1.7M | ﹤0.01% |
80,049
+65,772
| +461% | +$1.22M |
|
|
FFIC
2234
DELISTED
Flushing Financial
FFIC
| $1.7M | ﹤0.01% |
77,285
-6,416
| -8% | -$144K |
|
2235
Equinix
EQIX
$106B
| $1.69M | ﹤0.01% |
3,729
-29,438
| -89% | -$12M |
|
|
TXNM
2236
TXNM Energy Inc
TXNM
$5.93B
| $1.69M | ﹤0.01% |
35,700
-152,007
| -81% | -$6.65M |
|
2237
Welltower
WELL
$173B
| $1.69M | ﹤0.01% |
21,760
-494,086
| -96% | -$37.1M |
|
2238
WD-40
WDFC
$2.95B
| $1.69M | ﹤0.01% |
9,953
-2,271
| -19% | -$400K |
|
2239
MGM Resorts International
MGM
$10.9B
| $1.69M | ﹤0.01% |
65,673
-1,890,780
| -97% | -$51.9M |
|
2240
Rayonier
RYN
$6.16B
| $1.69M | ﹤0.01% |
58,910
-98,365
| -63% | -$2.62M |
|
2241
Primoris Services
PRIM
$4.14B
| $1.68M | ﹤0.01% |
81,405
+19,987
| +33% | +$421K |
|
2242
Aecom
ACM
$8.44B
| $1.68M | ﹤0.01% |
56,655
-33,142
| -37% | -$991K |
|
2243
Matsons
MATX
$6.66B
| $1.68M | ﹤0.01% |
46,520
+14,229
| +44% | +$492K |
|
2244
CALL
Ameriprise Financial
AMP
$49.1B
| $1.68M | ﹤0.01% |
13,100
+5,500
| +72% | +$683K |
|
|
HR
2245
DELISTED
Healthcare Realty Trust Incorporated
HR
| $1.68M | ﹤0.01% |
+52,259
| New | +$1.64M |
|
2246
Primerica
PRI
$9B
| $1.68M | ﹤0.01% |
13,729
-11,068
| -45% | -$1.28M |
|
2247
Cytokinetics
CYTK
$11B
| $1.68M | ﹤0.01% |
207,239
+20,156
| +11% | +$148K |
|
|
VRTV
2248
DELISTED
VERITIV CORPORATION
VRTV
| $1.68M | ﹤0.01% |
63,624
-9,999
| -14% | -$306K |
|
2249
Immersion
IMMR
$260M
| $1.67M | ﹤0.01% |
198,282
+5,155
| +3% | +$47.3K |
|
|
PDCE
2250
DELISTED
PDC Energy, Inc.
PDCE
| $1.67M | ﹤0.01% |
40,997
-432,869
| -91% | -$15.8M |
|
Similar funds
David Shaw's Q1 2019 Portfolio in Review
As of Q1 2019, David Shaw held 4,169 positions worth $77.4B, up 6.6% from $72.6B the previous quarter. Its ten largest holdings account for 9% of the portfolio.
David Shaw withdrew a net $2.66B in Q1 2019, closing 617 positions and reducing 1,599 holdings. Its most notable exit was Shire pic, an estimated $276M position sold in full.
By sector, the portfolio is most concentrated in Miscellaneous at 23% of assets, down from 26% a quarter earlier, followed by Technology and Healthcare.
Against the trend, David Shaw opened a new position in Lyft worth $159M.
- David Shaw's largest Q1 2019 buy was Lyft: 2,245,851 shares worth $159M.
- David Shaw added most to Pfizer in Q1 2019, an estimated $436M increase.
- David Shaw's biggest Q1 2019 reduction was Bristol-Myers Squibb, cutting an estimated $407M.
- David Shaw fully exited Shire pic in Q1 2019, selling an estimated $276M.
- David Shaw's ten largest holdings make up 9% of its $77.4B portfolio in Q1 2019.
- David Shaw opened 447 new positions and closed 617 in Q1 2019.
- David Shaw's portfolio value rose 6.6% quarter-over-quarter to $77.4B.
Based on D.E. Shaw & Co's 13F filing for Q1 2019, filed 15 May 2019.